Apollon Formularies (AQSE:APOL) Days Inventory : 0.00 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Apollon Formularies's Average Total Inventories for the six months ended in Jun. 2023 was £0.00 Mil. Apollon Formularies's Cost of Goods Sold for the six months ended in Jun. 2023 was £0.00 Mil.

The historical rank and industry rank for Apollon Formularies's Days Inventory or its related term are showing as below:

During the past 11 years, Apollon Formularies's highest Days Inventory was 19345.00. The lowest was 0.39. And the median was 0.50.

AQSE:APOL's Days Inventory is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 160.6
* Ranked among companies with meaningful Days Inventory only.

Apollon Formularies's Days Inventory stayed the same from Dec. 2021 (0.00) to Jun. 2023 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Apollon Formularies's Inventory-to-Revenue for the six months ended in Jun. 2023 was 0.00.

Apollon Formularies Days Inventory Historical Data

The historical data trend for Apollon Formularies's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies Days Inventory Chart

Apollon Formularies Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Days Inventory

Get a 7-Day Free Trial

0.39

0.50

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Days Inventory	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Apollon Formularies's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's Days Inventory distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's Days Inventory falls into.

Apollon Formularies Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Apollon Formularies's Days Inventory for the fiscal year that ended in Dec. 2021 is calculated as

	Days Inventory (A: Dec. 2021 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2020 )	+	Total Inventories (A: Dec. 2021 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2021 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Apollon Formularies's Days Inventory for the quarter that ended in Jun. 2023 is calculated as:

	Days Inventory (Q: Jun. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2022 )	+	Total Inventories (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 2
=	0					/	0	*	365 / 2
=	N/A

Apollon Formularies (AQSE:APOL) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Apollon Formularies's Inventory Turnover for the six months ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Apollon Formularies's Inventory to Revenue for the six months ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0.048
	=	0.00

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Apollon Formularies Days Inventory Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.